MO
BHC icon

McMillan Office’s Bausch Health BHC Stock Holding History

McMillan Office’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Hold
300
– – ﹤0.01% 469
2026
Q1 		$1.62K Hold
300
– – ﹤0.01% 459
2025
Q4 		$2.08K Buy
+300
New +$1.97K ﹤0.01% 449

Other funds holding BHC

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

McMillan Office's BHC Position: Q2 2026 in Review

McMillan Office held its Bausch Health (BHC) position steady in Q2 2026 at 300 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

McMillan Office first reported a position in BHC in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.08K in Q4 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • McMillan Office held 300 shares of Bausch Health worth $1.48K as of Q2 2026.
  • McMillan Office left its Bausch Health share count unchanged in Q2 2026.
  • Bausch Health made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #469 holding.
  • McMillan Office first reported a position in Bausch Health in Q4 2025 and has held it in 3 quarters since.
  • McMillan Office's Bausch Health position peaked at $2.08K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.